Search Results - "Fernández Grecco, Horacio"
-
1
Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages
Published in Haematologica (Roma) (01-04-2015)Get full text
Journal Article -
2
In Vitro Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia
Published in Frontiers in oncology (26-07-2021)“…Current standard treatment of patients with hairy cell leukemia (HCL), a chronic B-cell neoplasia of low incidence that affects the elderly, is based on the…”
Get full text
Journal Article -
3
The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406
Published in The Journal of immunology (1950) (15-09-2014)“…Chronic lymphocytic leukemia (CLL) is characterized by the progressive accumulation of clonal B lymphocytes. Proliferation occurs in lymphoid tissues upon…”
Get full text
Journal Article -
4
Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
Published in Haematologica (Roma) (01-09-2020)Get full text
Journal Article -
5
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia
Published in Cancer Immunology, Immunotherapy (01-05-2020)“…Despite significant therapeutic improvements chronic lymphocytic leukemia (CLL) remains an incurable disease and there is a persistent pursuit of new treatment…”
Get full text
Journal Article -
6
-
7
Revisiting the role of interleukin-8 in chronic lymphocytic leukemia
Published in Scientific reports (16-11-2017)“…The proliferation and survival of malignant B cells in chronic lymphocytic leukemia (CLL) depend on signals from the microenvironment in lymphoid tissues…”
Get full text
Journal Article -
8
Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis
Published in Blood cancer journal (New York) (05-11-2018)Get full text
Journal Article -
9
Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells
Published in Haematologica (Roma) (01-07-2017)Get full text
Journal Article -
10
Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs)
Published in Cancer Immunology, Immunotherapy (01-01-2017)“…Chronic lymphocytic leukemia (CLL) is characterized by immune defects that contribute to a high rate of infections and autoimmune cytopenias. Neutrophils are…”
Get full text
Journal Article -
11
Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype
Published in Cancer Immunology, Immunotherapy (01-04-2022)“…Venetoclax treatment has demonstrated efficacy and a safety profile in chronic lymphocytic leukemia (CLL) patients, however the emergence of resistant cells is…”
Get full text
Journal Article -
12
Second generation BTK inhibitors impair the anti‐fungal response of macrophages and neutrophils
Published in American journal of hematology (01-07-2020)Get full text
Journal Article -
13
Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16highCD62Ldim immunosuppressive subset
Published in International journal of cancer (01-03-2019)“…Reprogramming of neutrophils by malignant cells is well‐described for many types of solid tumors, but data remain scarce for hematological diseases. Chronic…”
Get full text
Journal Article -
14
Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
Published in Haematologica (Roma) (01-09-2020)Get full text
Journal Article -
15
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients
Published in Cancer Immunology, Immunotherapy (01-04-2017)“…Small molecules targeting kinases involved in B cell receptor signaling are showing encouraging clinical activity in chronic lymphocytic leukemia (CLL)…”
Get full text
Journal Article -
16
The effect of ibrutinib on neutrophil and γδ T cell functions
Published in Leukemia & lymphoma (23-08-2020)“…Ibrutinib is a BTK/ITK inhibitor with efficacy for the treatment of various lymphoid cancers, including CLL. Considering that innate and adaptative immune…”
Get full text
Journal Article -
17
-
18
Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16 high CD62L dim immunosuppressive subset
Published in International journal of cancer (01-03-2019)“…Reprogramming of neutrophils by malignant cells is well-described for many types of solid tumors, but data remain scarce for hematological diseases. Chronic…”
Get full text
Journal Article -
19
Efficacy of a Short Course of Chemotherapy with ABVD for Elderly Patients with Hodgkin Lymphoma for All Disease Stages
Published in Blood (08-12-2017)“…INTRODUCTION Treatment of classical Hodgkin's lymphoma (cHL) in the elderly population remains a challenge. Prevalence of co morbidities, increased toxicity to…”
Get full text
Journal Article -
20
Sphingosine Kinases (SK): Key Molecules Associated with the Activation, Proliferation and Ibrutinib-Induced Cell Death of Chronic Lympocytic Leukemia Cells
Published in Blood (03-12-2015)“…Leukemic cells from CLL patients can survive and proliferate within lymphoid tissues where the supportive microenvironment favors their accumulation. We have…”
Get full text
Journal Article